The estimated Net Worth of Joseph F Flanagan is at least 3.35 百万$ dollars as of 31 December 2021. Mr. Flanagan owns over 3,858 units of Integer Corp stock worth over 1,716,390$ and over the last 7 years he sold ITGR stock worth over 734,331$. In addition, he makes 901,721$ as Executive Vice President - Quality and Regulatory Affairs at Integer Corp.
Sign up
Mr. Flanagan ITGR stock SEC Form 4 insiders trading
Joseph has made over 8 trades of the Integer Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 3,858 units of ITGR stock worth 479,357$ on 31 December 2021.
The largest trade he's ever made was exercising 13,633 units of Integer Corp stock on 3 December 2018 worth over 281,521$. On average, Joseph trades about 2,366 units every 98 days since 2017. As of 31 December 2021 he still owns at least 13,814 units of Integer Corp stock.
You can see the complete history of Mr. Flanagan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joseph Flanagan biography
Joseph Flanagan serves as Executive Vice President - Quality and Regulatory Affairs of the Company. In February 2018, he assumed leadership for the Integer Business Process Excellence strategic imperative. From January 2012 until the Company’s acquisition of Lake Region Medical in October 2015, he was Vice President of Quality and Regulatory Affairs for Lake Region Medical. Prior to joining Lake Region Medical, Mr. Flanagan served as Vice President of Quality and Regulatory Affairs for NP Medical from April 2008 until January 2012.
What is the salary of Joseph Flanagan?
As the Executive Vice President - Quality and Regulatory Affairs of Integer Corp, the total compensation of Joseph Flanagan at Integer Corp is 901,721$. There are 6 executives at Integer Corp getting paid more, with Joseph Dziedzic having the highest compensation of 5,744,890$.
How old is Joseph Flanagan?
Joseph Flanagan is 61, he's been the Executive Vice President - Quality and Regulatory Affairs of Integer Corp since 2015. There are 6 older and 18 younger executives at Integer Corp. The oldest executive at Integer Holdings Corp is Bill Sanford, 76, who is the Independent Chairman of the Board.
Insiders trading at Integer Corp
Over the last 8 years, insiders at Integer Corp have traded over 11,995,808$ worth of Integer Corp stock and bought 28,350 units worth 1,274,625$ . The most active insiders traders include Thomas J Hook、Filippo Passerini、Martin C Maxwell. On average, Integer Corp executives and independent directors trade stock every 14 days with the average trade being worth of 717,544$. The most recent stock trade was executed by Diron Smith on 1 September 2024, trading 168 units of ITGR stock currently worth 20,874$.
What does Integer Corp do?
integer holdings corporation (nyse:itgr) is a leader in advanced medical device outsourcing (mdo) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. integer's vision is to enhance the lives of patients worldwide by being its customer's partner of choice for innovative medical technologies and services. additionally, through electrochem, an integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. the company's medical device manufacturing brands include greatbatch™ medical and lake region medical™. additional information is available at www.integer.net.
What does Integer Corp's logo look like?
Complete history of Mr. Flanagan stock trades at Integer Corp
Integer Corp executives and stock owners
Integer Corp executives and other stock owners filed with the SEC include:
-
Joseph Dziedzic,
President, Chief Executive Officer, Director -
Joseph W. Dziedzic,
Pres, CEO & Director -
Jason Garland,
Chief Financial Officer, Executive Vice President -
Kirk Thor,
Chief Human Resource Officer, Executive Vice President -
Payman Khales,
President - Cardio and Vascular -
Jennifer Bolt,
Senior Vice President - Global Operations -
Joseph Flanagan,
Executive Vice President - Quality and Regulatory Affairs -
Jason K. Garland,
Exec. VP & CFO -
Payman Khales,
Pres of Cardio & Vascular -
Jennifer M. Bolt,
Sr. VP of Global Operations & ESG -
Joel D. Becker,
Pres of Cardiac Rhythm Management & Neuromodulation -
Bill Sanford,
Independent Chairman of the Board -
Jean Hobby,
Independent Director -
Martin Maxwell,
Independent Director -
Pamela Bailey,
Independent Director -
James Hinrichs,
Independent Director -
William Summers,
Independent Director -
Donald Spence,
Independent Director -
Filippo Passerini,
Independent Director -
Anthony Borowicz,
Senior Vice President, Strategy, Corporate Development -
Joel Becker,
President, CRM & Neuromodulation -
Margaret Carthy,
Sr. VP of Quality and Regulatory Affairs -
Kirk K. Thor,
Exec. VP & Chief HR Officer -
McAlister C. Marshall II,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Elizabeth K. Giddens,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Carter Houghton,
Pres of Portable Medical & Electrochem -
Margaret Carthy,
EVP, Qlty & Regulatory Affairs -
Jeremy Friedman,
EVP, COO -
Gary J Haire,
EVP & Chief Financial Officer -
Thomas J Hook,
President & CEO -
Declan Smyth,
Pres., Advanced Surgical, Orth -
Jose Antonio Gonzalez,
President, CRM & Neuro -
Peter H Soderberg,
Director -
Kristin Trecker,
Chief Human Resource Officer -
Timothy G Mc Evoy,
Sr. VP, Gen. Counsel & Sec. -
Thomas J Mazza,
VP, Corporate Controller -
John A Harris,
EVP, Global Ops and Manufactur -
Michael L Spencer,
Chief Ethics & Compliance Of -
Tommy P Thomas,
VP, Corporate Controller -
Diron Smith,
EVP, Chief Financial Officer -
Carter Houghton,
President, Electrochem -
Elizabeth Giddens,
SVP, General Counsel -
Jim Stephens,
President, CRM & Neuro -
Alvin Tyrone Jeffers,
Director -
Sheila Antrum,
Director -
Cheryl C Capps,
Director -
Mc Alister C Ii Marshall,
SVP, Gen Counsel & Secretary -
Andrew Senn,
SVP, Strategy and Business Dev